October 01, 2016 3:23 AM ET

Biotechnology

Company Overview of Arbutus Biopharma Corporation

Executive Profile

Michael J. Abrams Ph.D.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 7 different industries.

See Board Relationships
60--
As of Fiscal Year 2014

Background

Dr. Michael J. Abrams, also known as Mike, Ph.D., has been Managing Director of Tekmira Pharmaceuticals Corporation since July 31, 2015 and served as its Chief Discovery Officer and Executive Vice President of Tekmira Pharmaceuticals Corporation since January 6, 2014. Dr. Abrams has been a Managing Director of Arbutus Biopharma Corporation since July 31, 2015. Dr. Abrams served as Corporate Secretary of Spartan Bioscience, Inc. He served as Scientific Advisor of Tarix ...

Corporate Headquarters

100-8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8

Canada

Phone: 604-419-3200
Fax: 604-419-3201

Board Members Memberships

2001-Present
Director

Education

PhD 1983
Massachusetts Institute of Technology
BA 1978
Bowdoin College
Unknown/Other Education
University Of Ottawa

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph W. Ramelli Chairman, Interim Chief Executive Officer, Interim President, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Marina Biotech, Inc.
--
Gregory West CAChief Executive Officer and Company Secretary
Benitec Biopharma Limited
$402.3K
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
$446.5K
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
$490.0K
Robert W. Overell Ph.D.Co-Founder, Chief Executive Officer, President and Director
PhaseRx, Inc.
$324.2K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Arbutus Biopharma Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.